Cargando…

Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology

Cancer cells frequently overexpress specific surface receptors providing tumor growth and survival which can be used for precise therapy. Targeting cancer cell receptors with protein toxins is an attractive approach widely used in contemporary experimental oncology and preclinical studies. Methods o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shilova, Olga, Shramova, Elena, Proshkina, Galina, Deyev, Sergey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124712/ https://www.ncbi.nlm.nih.gov/pubmed/34067057 http://dx.doi.org/10.3390/ijms22094975

Ejemplares similares

Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology
por: Shilova, Olga, et al.
Publicado: (2021)

Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape
por: Shramova, Elena, et al.
Publicado: (2020)

DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in Mice
por: Proshkina, Galina M., et al.
Publicado: (2021)

Novel Small Multilamellar Liposomes Containing Large Quantities of Peptide Nucleic Acid Selectively Kill Breast Cancer Cells
por: Proshkina, Galina, et al.
Publicado: (2022)

Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors
por: Shramova, Elena I., et al.
Publicado: (2022)

Near-Infrared Activated Cyanine Dyes As Agents for Photothermal Therapy and Diagnosis of Tumors
por: Shramova, E. I., et al.
Publicado: (2020)

Flavoprotein miniSOG Cytotoxisity Can Be Induced By Bioluminescence Resonance Energy Transfer
por: Shramova, E.I., et al.
Publicado: (2016)

Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted Phototoxic Protein DARPinminiSOG
por: Shilova, O. N., et al.
Publicado: (2015)

HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model
por: Sokolova, Evgeniya A., et al.
Publicado: (2019)

The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth
por: Sokolova, E.A., et al.
Publicado: (2017)

Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors
por: Vorobyeva, Anzhelika, et al.
Publicado: (2018)

Genetically Encoded Immunophotosensitizer 4D5scFv-miniSOG is a Highly Selective Agent for Targeted Photokilling of Tumor Cells In Vitro
por: Mironova, Kristina E., et al.
Publicado: (2013)

Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier Delivery
por: Shipunova, Victoria O., et al.
Publicado: (2021)

DARPins: Promising Scaffolds for Theranostics
por: Shilova, O. N., et al.
Publicado: (2019)

Lifespan and Stress Resistance in Drosophila with Overexpressed DNA Repair Genes
por: Shaposhnikov, Mikhail, et al.
Publicado: (2015)

An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry
por: Le Tourneau, Christophe, et al.
Publicado: (2022)

Epithelial cell adhesion molecule-targeting designed ankyrin repeat protein-toxin fusion Ec1-LoPE exhibits potent cytotoxic action in prostate cancer cells
por: Xu, Tianqi, et al.
Publicado: (2022)

The Mechanism of Fluorescence Quenching of Protein Photosensitizers Based on miniSOG During Internalization of the HER2 Receptor
por: Kuzichkina, E. O., et al.
Publicado: (2018)

Non-Oncological Radiotherapy: A Review of Modern Approaches
por: Nardone, Valerio, et al.
Publicado: (2022)

Modern Technologies for Creating Synthetic Antibodies for Clinical application
por: Deyev, S. M., et al.
Publicado: (2009)

Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission
por: Shipunova, Victoria O., et al.
Publicado: (2022)

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model
por: Xu, Tianqi, et al.
Publicado: (2023)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
por: Xu, Tianqi, et al.
Publicado: (2021)

Precision Oncology Comes of Age: Tumor-Agnostic Approaches
por: Lewis, Colleen, et al.
Publicado: (2020)

Synthetic Gene Expression Circuits for Designing Precision Tools in Oncology
por: Re, Angela
Publicado: (2017)

Challenges, opportunities, and innovative statistical designs for precision oncology trials
por: Yin, Jun, et al.
Publicado: (2022)

Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin
por: Sokolova, Evgeniya, et al.
Publicado: (2019)

miRNA therapeutics in precision oncology: a natural premium to nurture
por: Jain, Chakresh Kumar, et al.
Publicado: (2022)

Modern aspects of the use of natural polyphenols in tumor prevention and therapy
por: Sufianova, Galina, et al.
Publicado: (2022)

Targeting Cancer Cell Tight Junctions Enhances PLGA-Based Photothermal Sensitizers’ Performance In Vitro and In Vivo
por: Shipunova, Victoria O., et al.
Publicado: (2021)

Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
por: Yang, Jingjing, et al.
Publicado: (2022)

Actionability and precision oncology
por: Schwaederle, Maria, et al.
Publicado: (2015)

Bioinformatics for precision oncology
por: Singer, Jochen, et al.
Publicado: (2017)

The Future of Precision Oncology
por: Rulten, Stuart L., et al.
Publicado: (2023)

The Modern Technology of Radiation Oncology
por: Van Dyk, Jake
Publicado: (2017)

Ancient origin, functional conservation and fast evolution of DNA-dependent RNA polymerase III
por: Proshkina, Galina M., et al.
Publicado: (2006)

Ethical considerations of neuro-oncology trial design in the era of precision medicine
por: Gupta, Saksham, et al.
Publicado: (2017)

Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
por: Sorolla, Anabel, et al.
Publicado: (2019)

Primary refractory plasmablastic lymphoma: A precision oncology approach
por: Witte, Hanno M., et al.
Publicado: (2023)

Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology
por: Desai, Aakash, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o2psvfcig3fqlf5qhu0esj0404